Download original image
Fig. 8.

A proposed model for signaling pathways affected by UTD2 in breast cancer cells. By targeting tubulin and promoting tubulin polymerization, UTD2 inhibits the Rac1/PAK1/p38/MMP-2 signaling pathway, which is critical for the UTD2-induced actin cytoskeleton dysfunction. Meanwhile, the Rac1/PI3K/Akt/MMP-2 pathway may be also involved in UTD2-induced actin cytoskeleton dysfunction. In addition, represented by a thinner arrow in this model, UTD2 can moderately inhibit the Raf-MEK-ERK pathway. Together with the effect on survival factor Akt, these account for at least part of UTD2's antitumor activities.

Korean J Physiol Pharmacol 2014;18:109-120
© Korean J Physiol Pharmacol